Non-Interventional Enhanced Active Surveillance Study of Adults Vaccinated with AZD1222

Trial Identifier: D8111R00003
Sponsor: AstraZeneca
NCTID:: NCT04877743
Start Date: May 2021
Primary Completion Date: November 2021
Study Completion Date: November 2021

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
France Amiens, France, 80054
France ARGENTEUIL, France, 95107
Germany Essen, Germany, 45355
Germany Hamburg, Germany, 22143
Spain Logroño, Spain, 26006
Spain Mataró, Spain, 08303
Spain Monforte de Lemos, Spain, 27400
Spain Santiago de Compostela, Spain, 15706
Sweden Göteborg, Sweden, 405 45
Sweden Örebro, Sweden, 70185
Sweden Stockholm, Sweden, 11365